過活動膀胱治療の世界市場2021年ー2027年:薬物療法別(抗コリン作用薬-ソリフェナシン、オキシブチニン、フェソテロジン、ダリフェナシン;ミラベグロン; BOTOX;神経刺激、その他)、疾患タイプ別、地域別

◆英語タイトル:Global Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergic- Solifenacin, Oxybutynin, Fesoterodine, Darifenacin; Mirabegron; BOTOX; Neurostimulation, other), Disease Type (Idiopathic and Neurogenic Bladder Overactivity), Regional Forecasts 2021-2027
◆商品コード:BZW21JU159
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年6月30日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Research社は、2020年におよそ40億ドルであった過活動膀胱治療の世界市場規模が、2021年から2027年の間に2.93%以上の健全な成長率で成長すると予測しています。本調査レポートでは、世界の過活動膀胱治療市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬物療法別(抗コリン作用薬、ソリフェナシン、オキシブチニン、ダリフェナシン、フェソテロジン)分析、疾患タイプ別(特発性膀胱過活動、神経因性膀胱過活動)分析、地域別分析、競争状況、調査プロセスなど、以下の項目でまとめております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・過活動膀胱治療の世界市場規模:薬物療法別(抗コリン作用薬、ソリフェナシン、オキシブチニン、ダリフェナシン、フェソテロジン)
・過活動膀胱治療の世界市場規模:疾患タイプ別(特発性膀胱過活動、神経因性膀胱過活動)
・過活動膀胱治療の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Overactive Bladder Treatment Market is valued approximately at USD 4 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 2.93% over the forecast period 2021-2027. Overactive bladder is a frequent medical condition that causes a sudden need to urinate. Millions of individuals throughout the world suffer from overactive bladder, which is particularly frequent among the elderly. Urine leakage and increased urination frequency, which in patients is about eight times per day, are symptoms of an overactive bladder. Overactive bladder therapy refers to the many therapies used to treat the abrupt, involuntary contraction of the muscle in the urinary bladder wall. The market is driven by Assertive Marketing By Pharma Companies and development of Innovative Intravesical Therapies. For instance, UroGen Pharma Ltd. and The University of Texas MD Anderson Cancer Center announced today a three-year strategic cooperation agreement to enhance combinatorial intravesical immunotherapy for the treatment of high-grade non-muscle invasive bladder cancer. Furthermore, According to the National Association for Incontinence 2020, about 25 million adult Americans suffer with urine incontinence, with women accounting for 75-80% of the cases. On the other side, in 2017, According to the National Association for Incontinence, about 200 million persons worldwide suffered from urine incontinence. Because of the rising prevalence of bladder overactivity, the ageing population, rising healthcare costs, and increased education of overactive bladder treatments. However, Undesired Systemic Effects of Current OAB Treatments, may impede market growth over the forecast period of 2021-2027.

Geographically, the overactive bladder therapy market is expected to be dominated by North America. This is due to the fact that it has a well-established healthcare industry. The market is likely to grow over the forecast period, owing to reimbursement for overactive bladder therapy, increasing geriatric population , and the existence of competitors. However, Asia Pacific is the fastest growing region in the forecasting years 2020-2027.

Major market player included in this report are:
Intas Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Limited
Aurobindo Pharma Limited
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Macleods Pharmaceuticals Ltd.
Endo International PLC
Mylan N.V.
Apotex Inc.
Allergan, PLC.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Pharmacotherapy:
Anticholinergics
Solifenacin
Oxybutynin
Darifenacin
Fesoterodine
others

By Diseases type:
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Overactive Bladder Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Overactive Bladder Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2027 (USD Billion)
1.2.3. Overactive Bladder Treatment Market, by Disease type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Overactive Bladder Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Overactive Bladder Treatment Market Dynamics
3.1. Overactive Bladder Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Assertive Marketing By Pharma Companies
3.1.1.2. Development of Innovative Intravesical Therapies
3.1.2. Market Restraint
3.1.2.1. Undesired Systemic Effects of Current OAB Treatments
3.1.3. Market Opportunities
3.1.3.1. Novel Treatments, Robust Pipeline, and Patent Cliff of Certain Drugs
3.1.3.2. increasing occurrences of Parkinson’s disease, and multiple sclerosis and stroke
Chapter 4. Global Overactive Bladder Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Overactive Bladder Treatment Market , by Pharmacotherapy
5.1. Market Snapshot
5.2. Global Overactive Bladder Treatment Market by Pharmacotherapy , Performance – Potential Analysis
5.3. Global Overactive Bladder Treatment Market Estimates & Forecasts by Pharmacotherapy 2018-2027 (USD Billion)
5.4. Overactive Bladder Treatment Market , Sub Segment Analysis
5.4.1. Anticholinergics
5.4.2. Solifenacin
5.4.3. Oxybutynin
5.4.4. Darifenacin
5.4.5. Fesoterodine
5.4.6. Others
Chapter 6. Global Overactive Bladder Treatment Market , by Disease type
6.1. Market Snapshot
6.2. Global Overactive Bladder Treatment Market by disease Type, Performance – Potential Analysis
6.3. Global Overactive Bladder Treatment Market Estimates & Forecasts by disease type 2018-2027 (USD Billion)
6.4. Overactive Bladder Treatment Market , Sub Segment Analysis
6.4.1. Idiopathic Bladder Overactivity
6.4.2. Neurogenic Bladder Overactivity
Chapter 7. Global Overactive Bladder Treatment Market , Regional Analysis
7.1. Overactive Bladder Treatment Market , Regional Market Snapshot
7.2. North America Overactive Bladder Treatment Market
7.2.1. U.S. Overactive Bladder Treatment Market
7.2.1.1. Pharmacotherapy breakdown estimates & forecasts, 2018-2027
7.2.1.2. Disease type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Overactive Bladder Treatment Market
7.3. Europe Overactive Bladder Treatment Market Snapshot
7.3.1. U.K. Overactive Bladder Treatment Market
7.3.2. Germany Overactive Bladder Treatment Market
7.3.3. France Overactive Bladder Treatment Market
7.3.4. Spain Overactive Bladder Treatment Market
7.3.5. Italy Overactive Bladder Treatment Market
7.3.6. Rest of Europe Overactive Bladder Treatment Market
7.4. Asia-Pacific Overactive Bladder Treatment Market Snapshot
7.4.1. China Overactive Bladder Treatment Market
7.4.2. India Overactive Bladder Treatment Market
7.4.3. Japan Overactive Bladder Treatment Market
7.4.4. Australia Overactive Bladder Treatment Market
7.4.5. South Korea Overactive Bladder Treatment Market
7.4.6. Rest of Asia Pacific Overactive Bladder Treatment Market
7.5. Latin America Overactive Bladder Treatment Market Snapshot
7.5.1. Brazil Overactive Bladder Treatment Market
7.5.2. Mexico Overactive Bladder Treatment Market
7.6. Rest of The World Overactive Bladder Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Intas Pharmaceuticals Ltd.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Teva Pharmaceutical Industries Limited
8.2.3. Aurobindo Pharma Limited
8.2.4. Hisamitsu Pharmaceutical Co., Inc.
8.2.5. Johnson & Johnson
8.2.6. Macleods Pharmaceuticals Ltd.
8.2.7. Endo International PLC
8.2.8. Mylan N.V.
8.2.9. Apotex Inc.
8.2.10. Allergan, PLC.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Overactive Bladder Treatment Market , report scope
TABLE 2. Global Overactive Bladder Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Overactive Bladder Treatment Market estimates & forecasts by Pharmacotherapy 2018-2027 (USD Billion)
TABLE 4. Global Overactive Bladder Treatment Market estimates & forecasts by Disease type 2018-2027 (USD Billion)
TABLE 5. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of global Overactive Bladder Treatment Market .
TABLE 76. List of primary sources used in the study of global Overactive Bladder Treatment Market .
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.

List of figures
FIG 1. Global Overactive Bladder Treatment Market , research methodology
FIG 2. Global Overactive Bladder Treatment Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Overactive Bladder Treatment Market , key trends 2020
FIG 5. Global Overactive Bladder Treatment Market , growth prospects 2021-2027
FIG 6. Global Overactive Bladder Treatment Market , porters 5 force model
FIG 7. Global Overactive Bladder Treatment Market , pest analysis
FIG 8. Global Overactive Bladder Treatment Market , value chain analysis
FIG 9. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Overactive Bladder Treatment Market , regional snapshot 2018 & 2027
FIG 18. North America Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
FIG 19. Europe Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
FIG 22. Global Overactive Bladder Treatment Market , company market share analysis (2020)









【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[過活動膀胱治療の世界市場2021年ー2027年:薬物療法別(抗コリン作用薬-ソリフェナシン、オキシブチニン、フェソテロジン、ダリフェナシン;ミラベグロン; BOTOX;神経刺激、その他)、疾患タイプ別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆